Redmile Group, LLC Pliant Therapeutics, Inc. Transaction History

Redmile Group, LLC

  • $1.28 Billion
  • Q4 2024

A detailed history of Redmile Group, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 2,895,478 shares of PLRX stock, worth $3.91 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares
2,895,478
Previous 3,197,491 9.45%
Holding current value
$3.91 Million
Previous $35.8 Million 6.39%
% of portfolio
2.98%
Previous 2.34%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$10.55 - $15.7 $3.19 Million - $4.74 Million
-302,013 Reduced 9.45%
2,895,478 $38.1 Million
Q3 2024

Nov 14, 2024
SELL
$10.52 - $14.35 $127,292 - $173,635
-12,100 Reduced 0.38%
3,197,491 $35.8 Million
Q2 2024

Aug 14, 2024
BUY
$10.58 - $15.61 $1.19 Million - $1.75 Million
112,371 Added 3.63%
3,209,591 $34.5 Million
Q1 2024

May 15, 2024
BUY
$14.14 - $19.59 $5.66 Million - $7.85 Million
400,572 Added 14.85%
3,097,220 $46.1 Million
Q4 2023

Feb 14, 2024
BUY
$12.85 - $19.15 $238,354 - $355,213
18,549 Added 0.69%
2,696,648 $48.8 Million
Q2 2023

Aug 14, 2023
SELL
$18.12 - $30.56 $4.49 Million - $7.57 Million
-247,549 Reduced 8.46%
2,678,099 $48.5 Million
Q1 2023

May 15, 2023
SELL
$18.73 - $36.26 $17.8 Million - $34.6 Million
-952,951 Reduced 24.57%
2,925,648 $77.8 Million
Q4 2022

Feb 14, 2023
SELL
$17.0 - $25.43 $10.7 Million - $16 Million
-629,605 Reduced 13.97%
3,878,599 $75 Million
Q3 2022

Nov 14, 2022
BUY
$7.67 - $24.23 $11 Million - $34.9 Million
1,439,203 Added 46.89%
4,508,204 $94.2 Million
Q2 2022

Aug 15, 2022
SELL
$4.11 - $8.75 $48,498 - $103,250
-11,800 Reduced 0.38%
3,069,001 $24.6 Million
Q1 2022

May 16, 2022
SELL
$7.01 - $14.1 $18,927 - $38,070
-2,700 Reduced 0.09%
3,080,801 $21.6 Million
Q3 2021

Nov 15, 2021
SELL
$16.48 - $28.98 $1.2 Million - $2.11 Million
-72,900 Reduced 2.31%
3,083,501 $52 Million
Q2 2021

Aug 16, 2021
SELL
$28.05 - $37.69 $1.42 Million - $1.91 Million
-50,792 Reduced 1.58%
3,156,401 $91.9 Million
Q1 2021

May 17, 2021
SELL
$24.52 - $40.23 $4.44 Million - $7.29 Million
-181,183 Reduced 5.35%
3,207,193 $126 Million
Q4 2020

Feb 16, 2021
SELL
$19.89 - $32.99 $67,248 - $111,539
-3,381 Reduced 0.1%
3,388,376 $77 Million
Q3 2020

Nov 16, 2020
SELL
$21.54 - $29.53 $407,106 - $558,117
-18,900 Reduced 0.55%
3,391,757 $76.8 Million
Q2 2020

Aug 14, 2020
BUY
$21.3 - $35.26 $72.6 Million - $120 Million
3,410,657 New
3,410,657 $111 Million

Others Institutions Holding PLRX

# of Institutions
175
Shares Held
64.8M
Call Options Held
228K
Put Options Held
772K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $65.7M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email